(2-(7-Oxabicyclo[4.1.0]heptan-3-yl)ethyl)triethoxysilane

Catalog No. :
ACHPIL782
CAS No. :
10217-34-2
Molecular Formula :
C14H28O4Si
Molecular Weight :
288.46

IUPAC Name:(2-(7-oxabicyclo[4.1.0]heptan-3-yl)ethyl)triethoxysilane

(2-(7-Oxabicyclo[4.1.0]heptan-3-yl)ethyl)triethoxysilane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
500g98%$120.00Login to see priceIn stockInquiry
1000g98%$224.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2-(7-Oxabicyclo[4.1.0]heptan-3-yl)ethyl)triethoxysilane
IUPAC Name(2-(7-oxabicyclo[4.1.0]heptan-3-yl)ethyl)triethoxysilane
MDL No.MFCD00069159
Molecular FormulaC14H28O4Si
Molecular Weight288.46
SMILESCCO[Si](OCC)(CCC1CC2OC2CC1)OCC
InChI KeyUDUKMRHNZZLJRB-UHFFFAOYSA-N
Synonym?2-(3,4-Epoxycyclohexyl)ethyltriethoxysilane | CAS-10217-34-2 | 7-Oxabicyclo(4.1.0)heptane, 3-(2-(triethoxysilyl)ethyl)- | Triethoxy[2-(7-oxabicyclo[4.1.0]hept-3-yl)ethyl]silane | LS-14357 | A896879 | FT-0697185 | DTXSID7044762 | T3585 | NCGC00254656-01 |
CAS No.10217-34-2
PubChem CID154915

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H317-H412
Precautionary Statement(s)
P261-P272-P273-P280-P302+P352-P333+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACHPIL782 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHPIL782 route product structure diagram
    ACHPIL78210217-34-2 In Stock
Inquiry

2. ACHPIL782 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHPIL782 route product structure diagram
    ACHPIL78210217-34-2 In Stock
Inquiry

Comments (0)